Guo Y, Shang S, Liang L, Liu E
Discov Oncol. 2025; 16(1):290.
PMID: 40064736
PMC: 11893970.
DOI: 10.1007/s12672-025-02024-1.
Daily Z, Mohammed N, Mohammed S, Hussein H
Clin Cosmet Investig Dent. 2025; 17:147-158.
PMID: 40027983
PMC: 11869753.
DOI: 10.2147/CCIDE.S512557.
Xu J, Li N, Xie H, Duan C, Liao X, Li R
Transl Oncol. 2025; 53:102310.
PMID: 39929064
PMC: 11849657.
DOI: 10.1016/j.tranon.2025.102310.
Xu Y, Cai Q, Zhao C, Zhang W, Xu X, Lin H
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861077
PMC: 11768880.
DOI: 10.3390/ph18010012.
Bahrami A, Khalaji A, Najafi M, Sadati S, Raisi A, Abolhassani A
Eur J Med Res. 2024; 29(1):610.
PMID: 39702532
PMC: 11658081.
DOI: 10.1186/s40001-024-02168-w.
Closing Editorial: Colorectal Cancer-A Molecular Genetics Perspective.
Gharib E
Int J Mol Sci. 2024; 25(23).
PMID: 39684316
PMC: 11641827.
DOI: 10.3390/ijms252312604.
Research Progress of in the Treatment of Gastrointestinal Cancer.
Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J
Integr Cancer Ther. 2024; 23:15347354241302049.
PMID: 39610320
PMC: 11605761.
DOI: 10.1177/15347354241302049.
Uncovering disease-related multicellular pathway modules on large-scale single-cell transcriptomes with scPAFA.
Huang Z, Zheng Y, Wang W, Zhou W, Zhang Y, Wei C
Commun Biol. 2024; 7(1):1523.
PMID: 39550507
PMC: 11569158.
DOI: 10.1038/s42003-024-07238-7.
Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link.
Shahgoli V, Noorolyai S, Ahmadpour Youshanlui M, Saeidi H, Nasiri H, Mansoori B
Int J Colorectal Dis. 2024; 39(1):173.
PMID: 39465427
PMC: 11513726.
DOI: 10.1007/s00384-024-04748-y.
Heterogeneity of tumor microenvironment cell groups in inflammatory and adenomatous polyposis coli mutant colorectal cancer based on single cell sequencing.
Liang L, Zhang C, Han J, Liu Z, Liu J, Wu S
Transl Cancer Res. 2024; 13(9):4813-4826.
PMID: 39430845
PMC: 11483422.
DOI: 10.21037/tcr-24-689.
SEC14L3 knockdown inhibited clear cell renal cell carcinoma proliferation, metastasis and sunitinib resistance through an SEC14L3/RPS3/NFκB positive feedback loop.
Jiang Z, Yang G, Wang G, Wan J, Zhang Y, Song W
J Exp Clin Cancer Res. 2024; 43(1):288.
PMID: 39425205
PMC: 11490128.
DOI: 10.1186/s13046-024-03206-5.
Bioengineered Anthocyanin-Enriched Tomatoes: A Novel Approach to Colorectal Cancer Prevention.
Suzauddula M, Kobayashi K, Park S, Sun X, Wang W
Foods. 2024; 13(18).
PMID: 39335919
PMC: 11430996.
DOI: 10.3390/foods13182991.
5-Fluorouracil in Combination with Calcium Carbonate Nanoparticles Loaded with Antioxidant Thymoquinone against Colon Cancer: Synergistically Therapeutic Potential and Underlying Molecular Mechanism.
Deng X, Yang Z, Chan K, Ismail N, Bakar M
Antioxidants (Basel). 2024; 13(9).
PMID: 39334689
PMC: 11429434.
DOI: 10.3390/antiox13091030.
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.
Gharib E, Robichaud G
Int J Mol Sci. 2024; 25(17).
PMID: 39273409
PMC: 11395697.
DOI: 10.3390/ijms25179463.
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.
Pacifico T, Stolfi C, Tomassini L, Luiz-Ferreira A, Franze E, Ortenzi A
Cancer Sci. 2024; 115(11):3596-3611.
PMID: 39239848
PMC: 11531958.
DOI: 10.1111/cas.16317.
Polyphenols in the Prevention and Treatment of Colorectal Cancer: A Systematic Review of Clinical Evidence.
Lopez-Gomez L, Uranga J
Nutrients. 2024; 16(16).
PMID: 39203871
PMC: 11357634.
DOI: 10.3390/nu16162735.
Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.
Hamamah S, Lobiuc A, Covasa M
Int J Mol Sci. 2024; 25(16).
PMID: 39201713
PMC: 11354872.
DOI: 10.3390/ijms25169026.
TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancer.
Galbraith N, Quinn J, Al-Badran S, Pennel K, Hillson L, Hatthakarnkul P
Transl Oncol. 2024; 48:102064.
PMID: 39068768
PMC: 11338118.
DOI: 10.1016/j.tranon.2024.102064.
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers.
Mestrovic A, Perkovic N, Bozic D, Kumric M, Vilovic M, Bozic J
Biomedicines. 2024; 12(7).
PMID: 39062093
PMC: 11274502.
DOI: 10.3390/biomedicines12071520.
Aldo-keto reductases: Role in cancer development and theranostics.
Nagini S, Kallamadi P, Tanagala K, Reddy G
Oncol Res. 2024; 32(8):1287-1308.
PMID: 39055885
PMC: 11267078.
DOI: 10.32604/or.2024.049918.